Learn more

NOBEX CORP

Overview
  • Total Patents
    232
About

NOBEX CORP has a total of 232 patent applications. Its first patent ever was published in 1994. It filed its patents most often in United States, Canada and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are MEDPOINTE HEALTHCARE INC, DRUG DISCOVERY LAB AS and ONCONOVA THERAPEUTICS INC.

Patent filings per year

Chart showing NOBEX CORPs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Ekwuribe Nnochiri N 143
#2 Price Christopher H 64
#3 Ansari Aslam M 36
#4 Odenbaugh Amy L 33
#5 Ekwuribe Nnochiri 25
#6 Dyakonov Tatyana A 21
#7 Radhakrishnan Balasingam 20
#8 Ekwuribe Nnochiri Nkem 20
#9 James Kenneth D 18
#10 Riggs Jennifer A 18

Latest patents

Publication Filing date Title
US2007213262A1 Mixtures Of Calcitonin Drug-Oligomer Conjugates And Methods Of Use In Pain Treatment
CA2534298A1 Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same
TW200502251A Natriuretic compound conjugates, conjugates, and uses thereof
BR0316560A Natriuretic Compound Conjugate, Pharmaceutical Formulation, Method of Treating a Condition, Method of Preparing the Natriuretic Compound Conjugate, Modified Pro-Polynatriuretic Peptide Conjugate, Natriuretic Peptide Analog, hbnp Analogue, Compound, and Method of Preparing a Compound
AU2003285200A1 Modified carbamate-containing prodrugs and methods of synthesizing same
AU2003236521A8 Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
US7030082B2 Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
AU2002329989A1 Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US6770625B2 Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
US6867183B2 Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
ZA200202040B Taxane prodrugs.
ZA200202039B Amphiphilic prodrugs.
US7060675B2 Methods of treating diabetes mellitus
US6913903B2 Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
MXPA03001787A Immunoregulatory compounds, derivatives thereof and their use.
CA2421114A1 5-asa derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith
US6828297B2 Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6828305B2 Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6713452B2 Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6858580B2 Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same